biologics
Auto Added by WPeMatico
                    
          
                                 affordable cancer treatment
                           biologics
                           Business News
                           enzene biosciences
                           Health
                           HER2 breast cancer
                           Hetero Healthcare
                           HTDS News
                           oncology
                           pertuzumab biosimilar
                           Perzea
                           PNN News
                           Press Release
                           UNI News
                           
        
Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences
Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the synergy between two healthcare leaders committed to advanced cancer treatment accessibility. Innovation Meets […]
Read More